500 related articles for article (PubMed ID: 30683902)
1. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
Ha SY; Yeo SY; Xuan YH; Kim SH
PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
[TBL] [Abstract][Full Text] [Related]
3. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
[TBL] [Abstract][Full Text] [Related]
4. PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages.
Sakamoto H; Koma YI; Higashino N; Kodama T; Tanigawa K; Shimizu M; Fujikawa M; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2021 Mar; 101(3):353-368. PubMed ID: 33311557
[TBL] [Abstract][Full Text] [Related]
5. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
6. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
[TBL] [Abstract][Full Text] [Related]
7. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
Yang X; Lin Y; Shi Y; Li B; Liu W; Yin W; Dang Y; Chu Y; Fan J; He R
Cancer Res; 2016 Jul; 76(14):4124-35. PubMed ID: 27216177
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
10. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X
Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280
[TBL] [Abstract][Full Text] [Related]
12. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma.
Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S
Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141
[TBL] [Abstract][Full Text] [Related]
13. Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Watanabe S; Noma K; Ohara T; Kashima H; Sato H; Kato T; Urano S; Katsube R; Hashimoto Y; Tazawa H; Kagawa S; Shirakawa Y; Kobayashi H; Fujiwara T
Cancer Biol Ther; 2019; 20(9):1234-1248. PubMed ID: 31185791
[TBL] [Abstract][Full Text] [Related]
14. circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis.
Zhao Y; Jia Y; Wang J; Chen X; Han J; Zhen S; Yin S; Lv W; Yu F; Wang J; Xu F; Zhao X; Liu L
Mol Cancer; 2024 Mar; 23(1):47. PubMed ID: 38459511
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of FGFR2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of cancer-associated fibroblasts in the intratumoral stroma and invasive front in colorectal cancer.
Son GM; Kwon MS; Shin DH; Shin N; Ryu D; Kang CD
Medicine (Baltimore); 2019 May; 98(18):e15164. PubMed ID: 31045759
[TBL] [Abstract][Full Text] [Related]
17. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M; Noma K; Kato T; Nishimura S; Matsumoto H; Kawasaki K; Kunitomo T; Kobayashi T; Nishiwaki N; Kashima H; Kikuchi S; Ohara T; Tazawa H; Choyke PL; Kobayashi H; Fujiwara T
Br J Cancer; 2024 Jun; 130(10):1647-1658. PubMed ID: 38555315
[TBL] [Abstract][Full Text] [Related]
19. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer.
Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR
Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232
[TBL] [Abstract][Full Text] [Related]
20. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
